The size of the Europe Respiratory Monitoring Devices Market is expected to grow at a CAGR of 9.6% and reach USD 6.88 billion in 2027 from USD 4.35 billion in 2022. Respiratory Monitoring Devices are utilized to quantify the air we breathe in or breathe out, the amount of oxygen present in the blood, or the amount of carbon dioxide.
The increasing prevalence of respiratory diseases such as Asthma and Tuberculosis are majorly driving the European respiratory monitoring devices market. On the other hand, the growing population due to urbanization primarily contributes to the respiratory monitoring devices market.
In Europe, chronic obstructive pulmonary disease (COPD) is the most frequent life-threatening lung disease. According to WHO data, COPD affects over 66 million people globally, and it is projected to kill over 250 people per hour. COPD affects 4-10% of individuals in Europe, and it is currently the third most significant cause of death globally. However, COPD has become more common in Europe, affecting men and women almost equally due to high cigarette use in high-income countries. As a result, as the number of COPD cases rises, so does the market for respiratory monitoring.
The growing population and geriatric population are significantly influencing the respiratory monitoring devices market. In addition, as the senior population is prone to various respiratory disorders, tobacco smokers and associated lifestyles are driving the market growth. In addition, technological advancements in the healthcare sector and increasing demand for respiratory devices in private hospitals and clinics boost the market growth.
Increasing investments and funding by the government and private organizations, the introduction of smart respiratory monitoring devices by the major companies in the region, and rapid developments in healthcare infrastructure are encouraging market growth. Furthermore, the strategies implemented by the key market players in the area to gain a competitive advantage over the marketplace is likely to uplift the market growth. The strategies include partnerships, mergers, and acquisitions.
Infectious respiratory disorders, on the other hand, directly generate the need for respiratory care. The most recent and severe of these disorders is COVID-19, which has led to a rise in demand for personal protective equipment and ventilators, among other things. The need for ventilators has increased due to the COVID-19 outbreak, prompting government and industry support to accelerate production. As a consequence of the increased focus on respiratory treatment in the wake of an outbreak, the market is likely to grow strongly.
However, the high cost of medicines and doctor visits are expected to be the significant growth restraining factors of the market growth. In addition, the reimbursement concerns in the region limit the European respiratory monitoring devices market growth.
This research report on the European respiratory monitoring devices market has been segmented and sub-segmented into the following categories:
By Diagnostic Devices:
By Monitoring Devices:
By Country:
Geographically, this region holds the second highest share after North America in the global market because of its developed markets and significant players in this region.
The UK dominated the European respiratory monitoring devices market. It held the largest market share in 2020, and it is expected to register a significant share during the forecast period. The market growth is driven by the increasing prevalence of respiratory diseases, the growing geriatric population, and the high prevalence of tobacco smoking.
On the other hand, Germany is most likely to witness a considerable share in the respiratory monitoring devices market in the coming years. Enhancing PSG implementation in the healthcare industry, increasing patient demand for peak flow meters and pulse oximeters, and rising awareness about advanced therapies amongst people across the country are propelling the market growth.
KEY MARKET PLAYERS:
A few of the notable companies operating in the European respiratory monitoring devices market profiled in this report are Covidien GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc, Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Access Pharmaceuticals Inc., Sirnaomics Inc., and Traversa Therapeutics Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Diagnostic and Monitoring Devices
5.1.1 Introduction
5.1.2 Spirometers
5.1.3 Sleep Test Devices
5.1.4 Gas Analyzers
5.1.5 Pulse Oximeters
5.1.6 Peak Flow Meters
5.1.7 Capnographs
5.1.8 Y-o-Y Growth Analysis, By Diagnostic and Monitoring Devices
5.1.9 Market Attractiveness Analysis, By Diagnostic and Monitoring Devices
5.1.10 Market Share Analysis, By Diagnostic and Monitoring Devices
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Diagnostic and Monitoring Devices\
6.1.4 Market Attractiveness Analysis \
6.1.4.1 By Geographical Area
6.1.4.2 By Diagnostic and Monitoring Devices \
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Diagnostic and Monitoring Devices
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services 7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Covidien
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Philips Healthcare
8.4 Siemens Healthcare
8.5 Resmed
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
